A top US-based, multi-national oral care brand seeking to revamp its educational materials to better accommodate the evolving needs of a dental student population now primarily dominated by millennials. … Read More
A leading provider of high-quality, direct-to-consumer (DTC) dietary supplements sought out opportunities to build thought leadership in a rapidly growing market category. As competition increased via the introduction of mediocre players and formulas, a differentiation strategy that focused attention on the importance of quality was critical. … Read More
The global supply leader of Antarctic krill oil set a mission to improve the lives of systemic lupus erythematosus (SLE) patients. SPRIM helped the client understand the lupus community through qualitative and quantitative research. … Read More
A SPRIM initiated partnership: The GE Healthcare and Nestlé Health Science collaboration aims to connect the technology that delivers nutrients to the patient with the advanced analytic technology that measures the specific nutrition a patient needs. … Read More
A major oral care brand stepped outside of the box – eyeing an entry into skin care. SPRIM stepped in to help study the market and evaluate the options. SPRIM’s qualitative and quantitative analysis resulted in the client acquiring two skin care brands. … Read More
SPRIM developed an algorithm-based, broad-spectrum health assessment tool targeting several of the most critical risks to a person’s health and longevity. … Read More
SPRIM spearheaded a public-private partnership between Unilever and Abbott Nutrition and helped create an innovative solution to curb the progression of diabetes in India. A digital platform was created that more than 100,000 people in India used for lifestyle modifications. … Read More
The client engaged SPRIM to determine at-scale feasibility centering on scientific to operational potential, given the novel process of production the supplier demonstrated in its pilot facility. … Read More
SPRIM found innovation opportunities to promote adherence among rare disease patients through a competitive analysis and qualitative research. See how SPRIM changed the course for rare disease patients by helping a pharma company understand the loopholes within their own programs.
… Read More
A leading pharmaceutical company wanted to better understand early disease risks and gauge the potential for prevention. The client tasked SPRIM with identifying which diseases offered enough clinical data to enable clear risk identification and effective intervention prior to disease onset. … Read More
A major pet food company needed to change the formula to one of its dog foods. SPRIM conducted a complete analysis of the ingredients on the market and developed a new recipe. The new food is currently on the market today. … Read More